This important study, which tackles the challenge of analyzing genome integrity and instability in unicellular pathogens by introducing a novel single-cell genomics approach, presents compelling ...
In order to reprogram readily available cells into specific immune cells that fight various diseases, one must know the ...
Scientists have turned to artifacts associated with Leonardo da Vinci on a quest to track down the legendary polymath’s ...
Scientists at Rice University have unveiled a breakthrough technique that could fundamentally change how DNA is designed for ...
News Medical on MSN
“Recipe book” for reprogramming immune cells
In order to reprogram readily available cells into specific immune cells that fight various diseases, one must know the ...
The landscape of next-generation sequencing (NGS) continues to be defined by astonishing technological progress. We continue ...
Doctors at Duke University Hospital performed the first heart transplant of its kind, called donation after circulatory death ...
Zacks Small Cap Research on MSN
YDES: YD Biopharma is an integrated biotechnology company that is poised to have a transformational year as it expands business operations
YDES YD Bio (NASDAQ:YDES) is an integrated biotechnology company that combines diagnostics, precision medicine, and regenerative ophthalmology under a single commercial and development strategy. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback